Evidence map›Paper›PMID 29718933›Full record

ArticlePloS one2018

A20 regulates canonical wnt-signaling through an interaction with RIPK4.

Brooke N Nakamura, Alison Glazier, Michael G Kattah, Bao Duong, Yanxia Jia, Daniel Campo, Ling Shao

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. The Ubiquitin Proteasome System and Skin Fibrosis.Molecular diagnosis & therapy · 2021
    Review
  8. Article
  9. Identification of functional missense single-nucleotide polymorphisms inJournal of clinical and translational science · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Brooke N NakamuraDepartment of Medicine, Division of Gastroenterology and Liver Diseases, University of Southern California Keck School of Medicine, Los Angeles, California, United States of America.
Alison GlazierDepartment of Medicine, Division of Gastroenterology and Liver Diseases, University of Southern California Keck School of Medicine, Los Angeles, California, United States of America.
Michael G KattahDepartment of Medicine, Division of Gastroenterology, University of California, San Francisco, California, United States of America.
Bao DuongDepartment of Medicine, Division of Gastroenterology, University of California, San Francisco, California, United States of America.
Yanxia JiaDepartment of Medicine, Division of Gastroenterology and Liver Diseases, University of Southern California Keck School of Medicine, Los Angeles, California, United States of America.
Daniel CampoDepartment of Biological Sciences, University of Southern California, Los Angeles, California, United States of America.
Ling ShaoDepartment of Medicine, Division of Gastroenterology and Liver Diseases, University of Southern California Keck School of Medicine, Los Angeles, California, United States of America.ORCID 0000-0002-0285-9287
University of Southern California · USUniversity of California, San Francisco · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KAPLOWITZ, NEIL · 1995 to 2020
$21.8M
The Ubiquitin Editing Enzyme A20 Preserves Intestinal Epithelial Cell HomeostasisK08DK100462 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SHAO, LING · 2014 to 2018
$805k
Confocal Microscopy Imaging SystemS10RR022508 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OOKHTENS, MURAD · 2007 to 2007
$415k
NCI NIH HHS P30 CA014089NCRR NIH HHS S10 RR022508NIDDK NIH HHS K08 DK100462NIDDK NIH HHS P30 DK048522
6 · The paper itself

Abstract

A20 is a ubiquitin-editing enzyme that is known to regulate inflammatory signaling and cell death. However, A20 mutations are also frequently found in multiple malignancies suggesting a potential role as a tumor suppressor as well. We recently described a novel role for A20 in regulating the wnt-beta-catenin signaling pathway and suppressing colonic tumor development in mice. The underlying mechanisms for this phenomenon are unclear. To study this, we first generated A20 knockout cell lines by genome-editing techniques. Using these cells, we show that loss of A20 causes dysregulation of wnt-dependent gene expression by RNAseq. Mechanistically, A20 interacts with a proximal signaling component of the wnt-signaling pathway, receptor interacting protein kinase 4 (RIPK4), and regulation of wnt-signaling by A20 occurs through RIPK4. Finally, similar to the mechanism by which A20 regulates other members of the receptor interacting protein kinase family, A20 modifies ubiquitin chains on RIPK4 suggesting a possible molecular mechanism for A20's control over the wnt-signaling pathway.

Indexed as

Wnt Signaling PathwayGene Expression RegulationGene Knockout TechniquesHumansProtein BindingProtein Serine-Threonine KinasesTumor Necrosis Factor-alphaTumor Necrosis Factor alpha-Induced Protein 3UbiquitinationProtein Serine-Threonine KinasesRIPK4 protein, humanTNFAIP3 protein, humanTumor Necrosis Factor-alphaTumor Necrosis Factor alpha-Induced Protein 3

Identifiers

PMID29718933
PMCPMC5931457
OpenAlexW2799353335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.